ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2022 > Eastern Europe Lung Cancer Refresher (EE_Prog)
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

Eastern Europe Lung Cancer Refresher (EE_Prog)

9 ESCO credits

01.09.2022  -  03.09.2022

Vodice, Croatia


Lung cancer


Chairs: T. Cufer- SI, D. Jovanovic, RS

The Refresher Course on Lung Cancer is designed for medical and clinical oncologists of the Eastern Europe Region in order to provide an update on the state-of-the-art therapeutic options as well as an overview of the latest advances in the field of lung cancer.

The programme will offer educational lectures covering updates and future directions in diagnostic and treatment approaches in lung cancer; while real life case discussions will provide an ideal opportunity for multidisciplinary discussion. By presenting real life cases young oncologist will get an ideal opportunity to learn on how to best present and discuss their cases.


• Update on pathology and molecular testing in lung cancer
• Update on the latest advances in diagnostic procedures
• Update on the latest advances in targeted therapy and immunotherapy for lung cancer
• Update on modern surgical and radiation therapy approaches in lung cancer
• Get acquainted and put into perspective the latest guidelines
• Learn about the management of specific situations on lung cancer
• Debate controversies and challenges in lung cancer treatment
• Improve practical skills in multidisciplinary discussion and management of lung cancer patients



The official language will be English. No translation will be available.


The Eastern Europe Lung Refresher Course is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
It has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 10 European CME credits (ECMEC®s).
Each medical specialist should claim only those credits that he/she actually spent in the educational activity.
The EACCME® is an institution of the European Union of Medical Specialists (UEMS), www.uems.eu
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credits to AMA credits can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC® credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.


Attendance is limited to 30 participants and admittance is by competitive application only. Priority will be given to applicants who have attended a previous Eastern Europe Masterclass and or those practicing in this region.

Each past masterclass participant will be able to invite one colleague to apply, and further interested medical/clinical oncologists will be able to apply too.

Applicants who have not attended a previous Eastern Europe in Medical/Clinical Oncology should meet the following profile:

  • Age between 30 and 45 years
  • At least 2-3 years’ experience in medical oncology
  • Fluency in English
  • Practising in Eastern Europe

Successful applicants are granted free registration.

Accommodation at the course venue for arrival on 1 September and departure on 3 September will be provided to participants not residing in the Vodice area.


Dolores Knupfer
European School of Oncology (ESO)
Piazza Indipendenza 2
6500 Bellinzona
ph +41 91 820 09 52
e-mail: dknupfer@eso.net




Interested candidates should apply online providing:

If a candidate is not a past participant of a previous Eastern European Region Masterclass, the following documents should also be provided together with application template and abstract:

  • Letter describing motivation for attending
  • Short CV (template provided) with the list of publications (if the list of publication is not
    provided, it will be assumed that no articles have been published)


Applicants are requested to submit an abstract describing a clinical case related to lung cancer. Some admitted participants will have the opportunity to present the clinical case in the format of a clinical grand round discussion to the chairs, other faculty members and participants within plenary tumour board sessions in the programme. The application outcome will be notified by e-mail by the end of June.


1 September


2 September

8:30Welcome address and general introduction
Tanja Cufer, SI - Dragana Jovanovic, RS
8:40Lung cancer and COVID-19
Bakir Mehic, BA
9:00Screening for lung cancer: pros and cons
Mir Alireza Hoda, AT
9:30Histopathological diagnosis and molecular testing of lung cancer
Izidor Kern, SI
10:00EBUS/TNBA in diagnosis and staging of lung cancer
Bojan Zaric, RS
10:30Coffee break
11:00Treatment of SCLC
Dragana Jovanovic, RS
11:30Surgery for early NSCLC and SCLC
Mir Alireza Hoda, AT
13:30Adjuvant/neoadjuvant systemic therapy for early stage NSCLC
Tanja Cufer, SI
14:00Radiotherapy in combination with systemic therapies – a final answer for Stage III NSCLC?
Lucyna Kepka, PL
14:30Stereotactic radiotherapy - how to proceed in lung cancer?
Lucyna Kepka, PL
15:00Management of oligometastatic lung cancer -dilemmas and opportunities
Dragana Jovanovic, RS
15:30Coffee break
16:00Tumour board

3 September

8:30New frontiers in immunotherapy of advanced NSCLC
Giovanni Luca Ceresoli, IT
9:00Update on standard targeted therapy for NSCLC
Marko Jakopovic, HR
9:30Novel targets for molecular driven therapies in lung cancer
Giovanni Luca Ceresoli, IT
10:00Coffee break
10:30Radiological methods to assist primary diagnostics and treatment tailoring
Helmut Ringl, AT
11:00Tumour board
13:00Closing remarks
Tanja Cufer, SI - Dragana Jovanovic, RS


Giovanni Luca Ceresoli, Saronno Hospital, Medical Oncology Unit, Saronno, Italy
Tanja Cufer, University of Ljubljana, Medical Faculty, Ljubljana, SI
Mir Alireza Hoda, Medical University of Vienna, Division of Thoracic Surgery, Department of Surgery, Vienna, AT
Marko Jakopovic, University Hospital Centre Zagreb, Thoracic Oncology Unit, Zagreb, HR
Dragana Jovanovic, Internal Medicine Clinic "Akta Medica", Dept. of Thoracic Oncology, Belgrade, RS
Lucyna Kepka, Military Institute of Medicine, Radiotherapy Dept., Warszawa, PL
Izidor Kern, University Clinic Golnik, Dept. of Pathology, Golnik, SI
Bakir Mehic, Clinical Centre University of Sarajevo, Clinic of Lung Diseases, Sarajevo, BA
Helmut Ringl, Medical University Vienna, Vienna, AT, Oncology Dept., Vienna, AT
Bojan Zaric, Institute For Pulmonary Diseases of Vojvodina, Clinic for Thoracic Oncology, Sremska Kamenica, RS